About Owkin
Owkin is an AI precision medicine company with a vision to find the right drug for every patient.
Headquarters
Owkin, New York
Founded
2016-01-01
Industry
Artificial Intelligence (AI), Biotechnology, Clinical Trials, Machine Learning, Pharmaceutical, Precision Medicine
Last Funding Type
Series B
Valuation
3
Total Funding
$304.10 million dollars
IPO Status
Private
Financial
Owkin is advancing AI precision medicine through various research areas. They are developing systems for image classification and preprocessing, which involve segmenting images into regions of interest using convolutional neural networks. Their work includes detecting tertiary lymphoid structures in histology images and predicting breast cancer prognosis by analyzing whole slide images. Additionally, Owkin is focused on identifying features of pancreatic ductal adenocarcinoma from histopathology slides. These efforts highlight their commitment to enhancing diagnostic and prognostic capabilities in medicine.
Funding Rounds
8
Number of Lead Investors
8
Total Funding Amount
$304.10 million dollars
Number of Investors
16